Patient First: First Patient Dosed in Phase 1b Clinical Trial of SYN004 for the Prevention of C. difficile Infection

The first patient was dosed in a Phase 1b clinical trial of SYN004 an investigational oral betalactamase enzyme for the prevention of Clostridium difficile C. difficile infection antibioticassociated diarrhea and secondary antibioticresistant infections in...